PKA and Epac synergistically inhibit smooth muscle cell proliferation

Journal of Molecular and Cellular Cardiology

Volumn 50, Issue 1, 2011, Pages 87-98

  Hewer, Richard C ^a   Sala Newby, Graciela B ^a   Wu, Yih Jer ^b   Newby, Andrew C ^a   Bond, Mark ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

Author keywords

CAMP; Epac; PKA; Proliferation; Rap1; Vascular smooth muscle cell

Indexed keywords

ANTIPORTER; BROXURIDINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP 1; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; RAP1 PROTEIN; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GROWTH INHIBITION; INHIBITION KINETICS; MALE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STELLATE CELL; VASCULAR SMOOTH MUSCLE;

ACETYLCYSTEINE; ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ERYTHROMYCIN; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PAXILLIN; PHALLOIDINE; RAP1 GTP-BINDING PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 78650806852     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.10.010     Document Type: Article

References (46)

1. Izzard T., Taylor C., Birkett S., Jackson C., Newby A. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: role of the cyclin dependent kinases and their inhibitors. Cardiovasc Res 2002, 52:242-252.
2. Lewis C.D., Olson N.E., Raines E.W., Reidy M.A., Jackson C.L. Modulation of smooth muscle proliferation in rat carotid artery by platelet-derived mediators and fibroblast growth factor-2. Platelets 2001, 12:352-353.
3. Hedin U., Roy J., Tran P.K. Control of smooth muscle cell proliferation in vascular disease. Curr Opin Cell Biol 2004, 15:559-565.
4. Wu Y., Bond M., Sala-Newby G., Newby A. Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ Res 2006, 98:1141-1150.
5. Indolfi C., Avvedimento E.V., DiLorenzo E., Esposito G., Rapacciuolo A., Giuliano P., et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 1997, 3:775-779.
6. LAllemain G., Lavoie J., Rivard N., Baldin V., Pouyssegur J. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene 1997, 14:1981-1990.
7. Hayashi S., Morishita R., Matsushita H., Nakagami H., Taniyama Y., Nakamura T., et al. Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21. Hypertension 2000, 35:237-243.
8. Bond M., Wu Y.-J., Sala-Newby G., Newby A. Biphasic effect of p21Cip1 on vascular smooth muscle cell proliferation: role of PI3-kinase signalling and Skp2-mediated degradation. Cardiovasc Res 2005, 69:198-206.
9. Wu Y.J., Sala-Newby G.B., Shu K.T., Yeh H.I., Nakayama K.I., Nakayama K., et al. S-phase kinase-associated protein-2 (Skp2) promotes vascular smooth muscle cell proliferation and neointima formation in vivo. J Vasc Surg 2009, 50:1135-1142.
10. Lee H.T., Kay E.P. Regulatory role of cAMP on expression of Cdk4 and p27Kip1 by inhibiting phosphatidylinositol 3-kinase in corneal endothelial cells. Invest Ophthalmol Vis Sci 2003, 44:3816-3825.
11. Hecquet C., Lefevre G., Valtink M., Engelmann K., Mascarelli F. CAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 2002, 21:6101-6112.
12. de Rooij J., Zwartkruis F.J.T., Verheijen M.H.G., Cool R.H., Nijman S.M.B., Wittinghofer A., et al. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396:474-477.
13. Bos J. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci 2006, 31:680-686.
14. Kawasaki H., Springett G.M., Mochizuki N., Toki S., Nakaya M., Matsuda M., et al. A family of cAMP-binding proteins that directly activate Rap1. Science 1998, 282:2275-2279.
15. de Rooij J., Rehmann H., van Triest M., Cool R.H., Wittinghofer A., Bos J.L. Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 2000, 275:20829-20836.
16. Yokoyama U., Minamisawa S., Quan H., Akaike T., Jin M.H., Otsu K., et al. Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am J Physiol Heart Circ Physiol 2008, 295:H1547-H1555.
17. Gupta M., Yarwood S.J. MAP1A light chain 2 interacts with exchange protein activated by cyclic AMP 1 (EPAC1) to enhance Rap1 GTPase activity and cell adhesion. J Biol Chem 2005, 280:8109-8116.
18. Roscioni S.S., Elzinga C.R.S., Schmidt M. Epac: effectors and biological functions. Naunyn Schmiedeberg's Arch Pharmacol 2008, 377:345-357.
19. Hochbaum D., Hong K., Barila G., Ribeiro-Neto F., Altschuler D.L. Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis. J Biol Chem 2008, 283:4464-4468.
20. Haag S., Warnken M., Juergens U., Racke K. Role of Epac1 in mediating anti-proliferative effects of prostanoid EP2 receptors and cAMP in human lung fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2008, 378:617-630.
21. Wong L.F., Harding T., Uney J., Murphy D. cAMP-dependent protein kinase A mediation of vasopressin gene expression in the hypothalamus of the osmotically challenged rat. Mol Cell Neurosci 2003, 24:82-90.
22. Ohba Y., Mochizuki N., Matsuo K., Yamashita S., Nakata M., Hashimoto Y., et al. Rap2 as a slowly responding molecular switch in the Rap1 signaling cascade. Mol Cell Biol 2000, 20:6074-6083.
23. Christensen A.E., Selheim F., de Rooij J., Dremier S., Schwede F., Dao K.K., et al. cAMP analog mapping of Epac1 and cAMP kinase - discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 2003, 278:35394-35402.
24. Enserink J.M., Christensen A.E., de Rooij J., van Triest M., Schwede F., Genieser H.G., et al. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002, 4:901-906.
25. Enyeart J.A., Enyeart J.J. Metabolites of an Epac-selective cAMP analog induce cortisol synthesis by adrenocortical cells through a cAMP-independent pathway. PLoS ONE 2009, 4:e6088.
26. Enyeart J.A., Liu H., Enyeart J.J. cAMP analogues and their metabolites enhance TREK-1 mRNA and K+current expression in adrenocortical cells. Mol Pharmacol 2010, 77:469-482.
27. Poppe H., Rybalkin S.D., Rehmann H., Hinds T.R., Tang X.B., Christensen A.E., et al. Cyclic nucleotide analogues as probes of signaling pathways. Nat Meth 2008, 5:277-278.
28. Hogarth D.K., Sandbo N., Taurin S., Kolenko V., Miano J.M., Dulin N.O. Dual role of PKA in phenotypic modulation of vascular smooth muscle cells by extracellular ATP. Am J Physiol Cell Physiol 2004, 287:C449-C456.
29. Rubinfeld B., Munemitsu S., Clark R., Conroy L., Watt K., Crosier W.J., et al. Molecular-cloning of a GTPase activating protein-specific for the Krev-1 protein p21Rap1. Cell 1991, 65:1033-1042.
30. Tantini B., Manes A., Fiumana E., Pignatti C., Guarnieri C., Zannoli R., et al. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells. Basic Res Cardiol 2005, 100:131-138.
31. Cook S.J., Rubinfeld B., Albert I., McCormick F. RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 1993, 12:3475-3485.
32. Cook S.J., McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993, 262:1069-1072.
33. Hochbaum D., Tanos T., Ribeiro-Neto F., Altschuler D.L., Coso O. Activation of JNK by EPAC is independent of its activity as a Rap guanine nucleotide exchanger. J Biol Chem 2003, 278:33738-33746.
34. Assoian R.K., Zhu X.Y. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr Opin Cell Biol 1997, 9:93-98.
35. Bond M., Sala-Newby G., Newby A. Focal adhesion kinase (FAK)-dependent regulation of S-phase kinase-associated protein-2 (Skp-2) stability. J Biol Chem 2004, 279:37304-37310.
36. Cass L., Summers S., Prendergast G., Backer J., Birnaum M., MeinKoth J. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Mol Cell Biol 1999, 19:5882-5891.
37. Obara Y., Labudda K., Dillon T.J., Stork P.J.S. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci 2004, 117:6085-6094.
38. Schmitt J., Stork P. PKA phosphorylation of Src mediated cAMP's inhibition of cell growth via Rap1. Mol Cell 2002, 9:85-94.
39. Shi G., Rehmann H., Andres D. A novel cyclic AMP-dependent Epac-Rit signaling pathway contributes to PACAP38-mediated neuronal differentiation. Mol Cell Biol 2006, 26:9136-9147.
40. Howe A. Regulation of actin-based cell migration by cAMP/PKA. Biochim Biophys Acta: Mol Cell Res 2004, 1692:159-174.
41. Laulajainen M., Muranen T., Carpen O., Gronholm M. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton. Oncogene 2008 May, 27:3233-3243.
42. Pelletier S., Julien C., Popoff M., Lamarche-Vane N., Meloche S. Cyclic AMP induces morphological changes of vascular smooth muscle cells by inhibiting a Rac-dependent signaling pathway. J Cell Physiol 2005, 204:412-422.
43. Bond M., Wu Y.J., Sala-Newby G.B., Newby A.C. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo. Cardiovasc Res 2008, 80:290-298.
44. Cospedal R., Lobo M., Zachary I. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. Biochem J 1999, 342:407-414.
45. Giasson E., Servant M.J., Meloche S. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells. J Biol Chem 1997, 272:26879-26886.
46. Graves L.M., Bornfeldt K.E., Argast G.M., Krebs E.G., Kong X.M., Lin T.A., et al. Camp-sensitive and rapamycin-sensitive regulation of the association of eukaryotic initiation-factor 4e and the translational regulator Phas-I in aortic smooth-muscle cells. Proc Natl Acad Sci USA 1995, 92:7222-7226.